TScan Therapeutics, Inc (TCRX) insider trading
Every open-market stock purchase and sale by TScan Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $146K over the last 12 months (1 buy).
- Last insider buy: Lynx1 Capital Management LP (10% owner), $5.6K, 9 months ago.
Last 12 months: insiders bought $146K (1 buy) and sold $0 (0 sales). Last close $0.99 on Jun 7, 2026.
Recent TCRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 20, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| May 20, 2026 | Keith Woods (Insider) | Bought (not open market) | — |
| May 20, 2026 | Garry A Nicholson (Insider) | Bought (not open market) | — |
| May 20, 2026 | Barbara Klencke (Insider) | Bought (not open market) | — |
| May 20, 2026 | Gabriela Gruia (Insider) | Bought (not open market) | — |
| May 20, 2026 | Katina Dorton (Insider) | Bought (not open market) | — |
| Jan 20, 2026 | Chrystal Louis (C-suite exec) | Bought (not open market) | — |
| Jan 20, 2026 | Jason Amello (CFO) | Bought (not open market) | — |
| Jan 20, 2026 | Gavin MacBeath (CEO) | Bought (not open market) | — |
| Jan 20, 2026 | Leiden Dworak (Insider) | Bought (not open market) | — |
| Jan 20, 2026 | Zoran Zdraveski (Insider) | Bought (not open market) | — |
| Dec 23, 2025 | Lynx1 Capital Management LP (10% owner) | Bought | $5.6K |
| Dec 22, 2025 | Lynx1 Capital Management LP (10% owner) | Bought | $68K |
| Dec 19, 2025 | Lynx1 Capital Management LP (10% owner) | Bought | $72K |
Who's trading TCRX
- Barbara Klencke, Insider: other filings, last May 20, 2026
- Keith Woods, Insider: other filings, last May 20, 2026
- Garry A Nicholson, Insider: other filings, last May 20, 2026
- Katina Dorton, Insider: other filings, last May 20, 2026
- Baker Bros. Advisors LP, Insider: other filings, last May 20, 2026
- Gabriela Gruia, Insider: other filings, last May 20, 2026
- Zoran Zdraveski, Insider: other filings, last Jan 20, 2026
- Leiden Dworak, Insider: other filings, last Jan 20, 2026
- Chrystal Louis, C-suite exec: other filings, last Jan 20, 2026
- Gavin MacBeath, CEO: other filings, last Jan 20, 2026
- Jason Amello, CFO: other filings, last Jan 20, 2026
- Lynx1 Capital Management LP, 10% owner: bought $146K (3 buys), last Dec 23, 2025
Get free alerts when an insider at TScan Therapeutics, Inc files a new trade →